Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 315

1.

The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine.

Kawase M, Hoshina T, Yoneda T, Kojiro M, Takahashi Y, Kusuhara K.

J Infect Chemother. 2019 Sep 25. pii: S1341-321X(19)30271-5. doi: 10.1016/j.jiac.2019.09.001. [Epub ahead of print]

PMID:
31563335
2.

A Simple Assessment of the Eating and Swallowing Functions in Elderly Patients with Pneumonia.

Omori M, Chojin Y, Hashiki S, Kawanishi M, Kojiro M, Rikihisa M, Kato T.

J UOEH. 2019;41(3):283-294. doi: 10.7888/juoeh.41.283.

3.

Seasonality in clinical courses of Kawasaki disease.

Shimizu D, Hoshina T, Kawamura M, Tomita Y, Hidaka Y, Kojiro M, Muneuchi J, Kamizono J, Yamaguchi K, Fujino Y, Kusuhara K.

Arch Dis Child. 2019 Jul;104(7):694-696. doi: 10.1136/archdischild-2018-315267. Epub 2018 Nov 9.

PMID:
30413486
4.

Utility of the Performance of Lumbar Puncture for Febrile Children With Status Epilepticus in the Bacterial Conjugate Vaccine Era.

Haro K, Igarashi R, Hoshina T, Kojiro M, Kusuhara K.

Pediatr Infect Dis J. 2018 Oct;37(10):963-966. doi: 10.1097/INF.0000000000001945.

PMID:
29461450
5.

A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.

Hirayama T, Takazono T, Iwata K, Senju H, Shimazaki T, Tashiro M, Saijo T, Tanaka T, Nakamura S, Imamura Y, Kojiro M, Miyazaki T, Tsukamoto M, Furumoto A, Morimoto K, Muraosa Y, Matsubara Y, Yanagihara K, Mukae H, Kamei K, Kohno S, Izumikawa K.

J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8.

PMID:
28395939
6.

Difference between Japanese Secondary and Tertiary Medical Facilities Regarding Changes in the Hospitalization of Children for Pneumonia after the Introduction of the Pneumococcal Conjugate Vaccine.

Haro K, Ogawa M, Hoshina T, Kojiro M, Kusuhara K.

Jpn J Infect Dis. 2017 May 24;70(3):270-274. doi: 10.7883/yoken.JJID.2016.212. Epub 2016 Oct 31.

7.

[A Case of Clinically Mild Encephalitis/encephalopathy with a Reversible Splenial Lesion due to Dengue Fever].

Saito N, Kitashouji E, Kojiro M, Furumoto A, Morimoto K, Morita K, Ariyoshi K.

Kansenshogaku Zasshi. 2015 Jul;89(4):465-9. Japanese.

PMID:
26554222
8.

Diagnostic Accuracy of Recombinant Immunoglobulin-like Protein A-Based IgM ELISA for the Early Diagnosis of Leptospirosis in the Philippines.

Kitashoji E, Koizumi N, Lacuesta TL, Usuda D, Ribo MR, Tria ES, Go WS, Kojiro M, Parry CM, Dimaano EM, Villarama JB, Ohnishi M, Suzuki M, Ariyoshi K.

PLoS Negl Trop Dis. 2015 Jun 25;9(6):e0003879. doi: 10.1371/journal.pntd.0003879. eCollection 2015.

9.

Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy.

Yamamoto N, Sato K, Hoshina T, Kojiro M, Kusuhara K.

Mod Rheumatol. 2015;25(6):898-902. doi: 10.3109/14397595.2015.1038430. Epub 2015 May 27.

PMID:
25849851
10.

Contrast-enhanced ultrasonograpic studies on pancreatic carcinoma with special reference to staining and muscular arterial vessels.

Suga H, Okabe Y, Tsuruta O, Naito Y, Kinoshita H, Toyonaga A, Ono N, Oho K, Kojiro M, Sata M.

Kurume Med J. 2014;60(3-4):71-8. Epub 2014 Feb 17.

11.

[A case of pacemaker-lead infection by linezolid-resistant methicillin-resistant Staphylococcus aureus in a hemodialysis patient].

Kojiro M, Tsuchihashi Y, Ishida M, Furumoto A, Matsuda J, Yanagihara K, Morimoto K, Ariyoshi K.

Kansenshogaku Zasshi. 2012 Nov;86(6):778-83. Japanese.

PMID:
23367855
12.

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology.

Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.

PMID:
21829027
13.

Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?

Gouw AS, Balabaud C, Kusano H, Todo S, Ichida T, Kojiro M.

Liver Transpl. 2011 Oct;17 Suppl 2:S72-80. doi: 10.1002/lt.22368. Review. No abstract available.

14.

Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis.

Doi N, Tomiyama Y, Kawase T, Nishina S, Yoshioka N, Hara Y, Yoshida K, Korenaga K, Korenaga M, Moriya T, Urakami A, Nakashima O, Kojiro M, Hino K.

Intern Med. 2011;50(11):1193-9. Epub 2011 Jun 1.

15.

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.

Yoshida H, Shiratori Y, Kudo M, Shiina S, Mizuta T, Kojiro M, Yamamoto K, Koike Y, Saito K, Koyanagi N, Kawabe T, Kawazoe S, Kobashi H, Kasugai H, Osaki Y, Araki Y, Izumi N, Oka H, Tsuji K, Toyota J, Seki T, Osawa T, Masaki N, Ichinose M, Seike M, Ishikawa A, Ueno Y, Tagawa K, Kuromatsu R, Sakisaka S, Ikeda H, Kuroda H, Kokuryu H, Yamashita T, Sakaida I, Katamoto T, Kikuchi K, Nomoto M, Omata M.

Hepatology. 2011 Aug;54(2):532-40. doi: 10.1002/hep.24430. Epub 2011 Jun 26.

PMID:
21574174
16.

Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma.

Fukushima N, Kuromatsu R, Akiba J, Ando E, Takata A, Sumie S, Nakano M, Nakamura T, Kawahara A, Torimura T, Nakashima O, Okuda K, Yano H, Kage M, Kojiro M, Sata M.

Exp Ther Med. 2010 Sep;1(5):809-816. Epub 2010 Jul 21.

17.

Pathological diagnosis at early stage: reaching international consensus.

Kojiro M.

Oncology. 2010 Jul;78 Suppl 1:31-5. doi: 10.1159/000315227. Epub 2010 Jul 8.

PMID:
20616581
18.

Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.

Roskams T, Kojiro M.

Semin Liver Dis. 2010 Feb;30(1):17-25. doi: 10.1055/s-0030-1247129. Epub 2010 Feb 19. Review.

PMID:
20175030
19.

Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.

Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M; Liver Cancer Study Group of Japan.

AJR Am J Roentgenol. 2010 Mar;194(3):830-7. doi: 10.2214/AJR.09.3308.

PMID:
20173167
20.

Angiosarcoma of the breast with silicone granuloma: a case report.

Takenaka M, Tanaka M, Isobe M, Yamaguchi R, Kojiro M, Shirouzu K.

Kurume Med J. 2009;56(1-2):33-7.

21.

Clinicopathological study of hepatocellular carcinoma with peliotic change.

Fujimoto M, Nakashima O, Komuta M, Miyaaki T, Kojiro M, Yano H.

Oncol Lett. 2010 Jan;1(1):17-21. Epub 2010 Jan 1.

22.

Analysis of subendothelial leukocyte infiltration in the trabecular veins of septic spleen.

Takasu O, Sakamoto T, Kojiro M, Yano H.

Kurume Med J. 2010;57(1-2):9-20.

23.

Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.

Inoue T, Kudo M, Maenishi O, Komuta M, Nakashima O, Kojiro M, Maekawa K.

AJR Am J Roentgenol. 2009 Mar;192(3):698-705. doi: 10.2214/AJR.07.3282.

PMID:
19234266
24.

Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?

Malouf G, Falissard B, Azoulay D, Callea F, Ferrell LD, Goodman ZD, Hayashi Y, Hsu HC, Hubscher SG, Kojiro M, Ng IO, Paterson AC, Reynes M, Zafrani ES, Emile JF.

J Clin Pathol. 2009 Jun;62(6):519-24. doi: 10.1136/jcp.2008.062620. Epub 2009 Jan 20.

PMID:
19155239
25.

[Epithelioid hemangioendothelioma of the liver diagnosed by laparoscopy guided biopsy].

Komatsu N, Kurosaki M, Sato M, Tanaka T, Hirayama I, Yasui Y, Umeda N, Hosokawa T, Ueda K, Tuchiya K, Nakanishi H, Itakura J, Asahina Y, Akasaka H, Matsunaga K, Taki K, Kojiro M, Izumi N.

Nihon Shokakibyo Gakkai Zasshi. 2008 Nov;105(11):1640-7. Japanese.

PMID:
18987450
26.

[A case of hepatic eosinophilic granuloma, which needs distinction with metastatic liver cancer].

Saito F, Okabe Y, Suga H, Watanabe T, Arinaga T, Naito Y, Uchida S, Hisaka T, Toyonaga A, Kojiro M, Kinoshita H, Tsuruta O, Sata M.

Nihon Shokakibyo Gakkai Zasshi. 2008 Oct;105(10):1509-14. Japanese.

PMID:
18840990
27.

Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo.

Moriya F, Ogasawara S, Basaki Y, Akiba J, Kojiro S, Fukahori S, Ishizaki H, Nishida N, Matsuoka K, Kojiro M, Kuwano M, Yano H.

Int J Oncol. 2008 Oct;33(4):647-55.

PMID:
18813777
28.

Long-term follow-up of atypical progressive focal nodular hyperplasia increasing in size and number implicates its pathogenesis.

Kudo M, Zheng RQ, Chung H, Yonekura T, Yagi M, Nakashima O, Kojiro M.

Am J Gastroenterol. 2008 Aug;103(8):2153-5. doi: 10.1111/j.1572-0241.2008.01982_14.x. No abstract available.

PMID:
18796122
29.

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey.

Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I.

J Hepatol. 2008 Oct;49(4):589-94. doi: 10.1016/j.jhep.2008.05.018. Epub 2008 Jun 12.

PMID:
18620773
30.

Hepatocellular carcinoma with a "nodule-in-nodule" appearance reflecting an unusual dilated pseudoglandular structure.

Ishida Y, Nagamatsu H, Koga H, Yoshida H, Kojiro M, Sata M.

Intern Med. 2008;47(13):1215-8. Epub 2008 Jul 1.

31.

Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro.

Fukahori S, Yano H, Akiba J, Ogasawara S, Momosaki S, Sanada S, Kuratomi K, Ishizaki Y, Moriya F, Yagi M, Kojiro M.

Mol Med Rep. 2008 Jul-Aug;1(4):537-42.

PMID:
21479446
32.

Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.

Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M.

Intervirology. 2008;51 Suppl 1:17-26. doi: 10.1159/000122595. Epub 2008 Jun 10.

PMID:
18544944
33.

Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.

Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, Yano H, Suzuki T, Matsuda M, Fujii H, Desmet VJ, Kojiro M, Roskams T.

Hepatology. 2008 May;47(5):1544-56. doi: 10.1002/hep.22238.

PMID:
18393293
34.

Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report.

Soeda J, Yazaki M, Nakata T, Miwa S, Ikeda S, Hosoda W, Iijima M, Kobayashi K, Saheki T, Kojiro M, Miyagawa S.

J Clin Gastroenterol. 2008 Aug;42(7):855-60. doi: 10.1097/01.mcg.0000225683.29841.9c.

PMID:
18385606
35.

Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey.

Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, Ikai I, Kudo M, Kojiro M, Makuuchi M, Monden M, Matsuyama Y, Nakanuma Y, Takayasu K; Liver Cancer Study Group of Japan.

Surgery. 2008 Apr;143(4):469-75. doi: 10.1016/j.surg.2007.12.003.

PMID:
18374043
36.

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.

Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7.

PMID:
18324443
37.

Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.

Takahata T, Ookawa K, Suto K, Tanaka M, Yano H, Nakashima O, Kojiro M, Tamura Y, Tateishi T, Sakata Y, Fukuda S.

Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):399-407. doi: 10.1111/j.1742-7843.2007.00199.x. Epub 2008 Jan 30.

38.

Early hepatocellular carcinoma: pathology, imaging, and therapy.

Takayama T, Makuuchi M, Kojiro M, Lauwers GY, Adams RB, Wilson SR, Jang HJ, Charnsangavej C, Taouli B.

Ann Surg Oncol. 2008 Apr;15(4):972-8. doi: 10.1245/s10434-007-9685-0. Epub 2008 Jan 31. Review.

PMID:
18236118
39.

Case report of a focal nodular hyperplasia-like nodule present in cirrhotic liver.

Takahashi S, Miyanishi K, Takada K, Kawano Y, Sagawa T, Sato Y, Takimoto R, Takayama T, Kato J, Omatsu M, Hasegawa T, Kojiro M, Niitsu Y.

Hepatol Res. 2008 May;38(5):521-8. doi: 10.1111/j.1872-034X.2007.00294.x. Epub 2008 Jan 15.

PMID:
18201183
40.

Ductal carcinoma in situ arising in a benign phyllodes tumor: report of a case.

Yamaguchi R, Tanaka M, Kishimoto Y, Ohkuma K, Ishida M, Kojiro M.

Surg Today. 2008;38(1):42-5. Epub 2007 Dec 24.

PMID:
18085361
42.

Clinicopathological study of invasive ductal carcinoma with large central acellular zone: special reference to magnetic resonance imaging findings.

Yamaguchi R, Furusawa H, Nakahara H, Inomata M, Namba K, Tanaka M, Ohkuma K, Tayama K, Fujii T, Yano H, Kage M, Kojiro M.

Pathol Int. 2008 Jan;58(1):26-30.

PMID:
18067637
43.

Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma.

Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M, Tajiri T, Taguchi T, Tsuneyoshi M, Kojiro M.

J Pediatr Surg. 2007 Nov;42(11):1831-40.

PMID:
18022432
44.

Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West.

Kojiro M.

Hepatol Res. 2007 Sep;37 Suppl 2:S121-4.

PMID:
17877472
45.

Serum C-reactive protein levels predict survival in hepatocellular carcinoma.

Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M.

Liver Int. 2007 Oct;27(8):1091-7.

PMID:
17845537
46.

Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.

Ishizaki H, Yano H, Tsuneoka M, Ogasawara S, Akiba J, Nishida N, Kojiro S, Fukahori S, Moriya F, Matsuoka K, Kojiro M.

Pathol Int. 2007 Oct;57(10):672-80.

PMID:
17803656
47.

Mesenchymal hamartoma of the liver accompanied by a daughter nodule: report of a case.

Fukahori S, Tsuru T, Tanikawa K, Akiyoshi K, Asagiri K, Tanaka Y, Kage M, Kojiro M, Mizote H, Yagi M.

Surg Today. 2007;37(9):811-6. Epub 2007 Aug 27.

PMID:
17713740
48.

Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells.

Oie S, Ono M, Fukushima H, Hosoi F, Yano H, Maruyama Y, Kojiro M, Terada T, Hirano K, Kuwano M, Yamada Y.

Mol Cancer Ther. 2007 Aug;6(8):2310-8.

50.

Hyperplastic nodular hepatic lesions following end-to-side portacaval shunting in childhood.

Fukushima N, Kuromatsu R, Uchiyama D, Itano S, Takata A, Ando E, Sumie S, Torimura T, Uchida M, Nakashima O, Kojiro M, Sata M.

Intern Med. 2007;46(15):1203-8. Epub 2007 Aug 2.

Supplemental Content

Loading ...
Support Center